Radiotherapy (RT) for head and neck cancers causes salivary dysfunction and diminished
xerostomia-related quality of life. We have demonstrated that three-dimensional treatment …

Background. Our aim was to correlate patterns of failure with target volume delineations in
patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity …

PURPOSE: Parotid-sparing intensity-modulated radiotherapy (IMRT) for head-and-neck
cancer reduces xerostomia compared with standard RT. To assess potential improvements …

Background Xerostomia can have a significant impact on the quality of life of patients treated
by radiation therapy (RT) for cancer in the head and neck. The first aim of the study was to …

Abstract Background. Recently, the Quantitative Analysis of Normal Tissue Effect in the
Clinic (QUANTEC) Group defined dose-volume constraints for the parotid glands to avoid …

Backgroundandpurpose: Xerostomia is a significant morbidity of radiation treatment in the
management of head and neck cancers. We hypothesized that the surgical transfer of one …

Background. Radiation‐induced xerostomia is a frequent and usually permanent side effect
of radiation therapy for head and neck cancer. We summarize recent developments in the …

Purpose: Xerostomia is a severe complication after radiotherapy for oropharyngeal cancer,
as the salivary glands are in close proximity with the primary tumor. Intensity-modulated …

Background and purpose: To evaluate (1) parotid function,(2) subjective xerostomia and (3)
pattern of relapses after conformal parotid-sparing radiotherapy (RT) for head and neck …

The goals of this study were to facilitate sparing of the major salivary glands while
adequately treating tumor targets in patients requiring comprehensive bilateral neck …